InvestorsHub Logo

thefamilyman

02/21/21 1:45 AM

#347808 RE: falcon74 #347736

20% is ridiculously low unless that percentage increases substantially as total sales increase. If Brilacidin works against Covid, the governments of the world are going to write very large checks THIS YEAR. A big upfront payment is not worth much when the gross is going to dwarf the upfront payment in the short term. And giving 80% of the revenue to a “partner” who did NOTHING to get us to this point is an insult. Again, if Brilacidin works, we do NOT need a BP “partner”. We already contract the production and the finished product can be direct shipped to the appropriate address. All that remains is to deposit the checks (or just confirm that the proper funding was wired into our account).

After the Covid crisis has passed, I could see Leo signing with a BP to develop Brilacidin for innumerable uses (bacterial, virus, parasitic, IBD, biofilm, and perhaps even medical device coatings or other surface coatings that incorporate Brilacidin). But hopefully Leo is smart enough to negotiate a sliding scale of royalties that gets us to 50% after gross sales reach a billion or so.

Falcon said,

The royalty would probably be at least 20% of revenues but hopefully more like 30 to 40%.